Related Experiment Video
Updated: Jun 26, 2026
Left Lung Orthotopic Transplantation in a Juvenile Porcine Model for ESLP
Published on: February 14, 2022
Pediatric lung transplantation
1Department of Pediatrics, Washington University, St. Louis, MO 63110, USA. sweet@kids.wustl.edu
Insights
Pediatric lung transplantation offers a viable treatment for end-stage lung disease in children. Young children generally experience better outcomes, but adherence and bronchiolitis obliterans remain key challenges.
Area of Science:
- Pediatric Pulmonology
- Transplant Surgery
- Immunology
Background:
- Lung and heart-lung transplantation are crucial for pediatric end-stage pulmonary diseases.
- Pediatric patients present unique challenges, including specific diagnoses and higher ventilation needs.
- Infections pose significant complications before and after pediatric transplantation.
Purpose of the Study:
- To review the current state and outcomes of pediatric lung and heart-lung transplantation.
- To identify pediatric-specific challenges and areas for improvement in transplant care.
- To discuss long-term outcomes and major complications in pediatric transplant recipients.
Main Methods:
- Review of existing literature on pediatric lung and heart-lung transplantation.
- Analysis of outcomes, complications, and age-specific differences in pediatric transplant recipients.
- Discussion of challenges such as infection, rejection, and adherence.
Main Results:
- Overall outcomes for pediatric lung transplant recipients are comparable to adults.
- Younger children tend to have better outcomes, potentially due to lower rejection rates.
- Adolescents face poor long-term outcomes, and bronchiolitis obliterans is a major late complication.
Conclusions:
- Pediatric lung transplantation is a viable option for severe lung diseases.
- Addressing adherence issues in adolescents and managing bronchiolitis obliterans are critical for improving outcomes.
- Multicenter studies and standardized protocols are necessary to advance pediatric transplant care.
Abstract:
Pediatric lung and heart-lung transplantation are viable therapeutic interventions for end stage pulmonary parenchymal or pulmonary vascular diseases. Issues specific to pediatrics include unique diagnoses and increased need for mechanical ventilation before transplant and increased complications related to infection both before and after transplant. Although outcomes for children as a group are similar to those for adults, young children often fare better, perhaps in part due to reduced incidence of acute and chronic rejection. As in other solid organs, long-term outcomes in adolescents are poor. Increased focus on improving adherence in this age group will be important. Similar to adults, bronchiolitis obliterans remains the major late complication. Uniform treatment protocols and multicenter pediatric studies will be required to ultimately overcome this pervasive problem and improve pediatric lung transplant outcomes.
